We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FNV:NYSEFranco-Nevada Corporation Analysis

Data as of 2026-09-19 - not real-time

$265.93

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Franco-Nevada Corporation is priced at $265.93 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has gained 15.1%. Relative strength is 58.4 — neutral — and the MACD signal is bearish. Watch $254.41 as support and $273.98 as the nearer resistance level.
Valuation screens as overvalued, on a P/E of 34.7 with no clean sector comparison available. Consensus targets land 7.3% above where the shares trade now. Revenue is growing at 58.2% on a 64.2% profit margin. The 0.66% dividend yield looks covered by current payout levels.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 37.1%, a beta of 1.11 and a maximum drawdown of 29.4%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Timeframes disagree: the short-term read is buy while the long-term read is hold, conviction 3 out of 10.

Top Market Events

FNV's Q2 revenues jump 57% y/y, fueled by higher precious metal and oil prices, while earnings miss estimates and...Franco-Nevada Corp FNV reports a stellar Q2 2026 with record financial results, a 23% increase in precious metal GEOs,...Yahoo Finance1monFranco-Nevada Corp FNV Q2 2026 Earnings Call Highlights: Record Revenue Surge of 57% and .

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 235.60
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 235.60
  • Analyst targets imply +7.3% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Analyst targets imply +7.3% versus the current price
  • Profit margin of 64.2% is healthy
  • Revenue growth of +58.2%

Key Metrics & Analysis

Financial Health

Revenue Growth58.20%
Profit Margin64.23%
P/E Ratio34.7
ROE19.91%
ROA13.73%
P/B Ratio6.2
Op. Cash Flow$1.8B
Free Cash Flow$470.3M

Technical Analysis

TrendBullish
RSI58.4
Support$254.41
Resistance$273.98
MA 20$265.02
MA 50$238.58
MA 200$235.60
MACDBearish
VolumeStable
Fear & Greed Index94.98

Valuation

Fair Value$87.30
Target Price$285.30
Upside/Downside7.29%
GradeOvervalued
TypeGrowth
Dividend Yield0.66%

Risk Assessment

Beta1.11
Volatility37.08%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.